99% Savings - Buy Just @1 Rs X
Oncophos 1000 mg Infusion is a commercial drug that is prescribed in the form of Infusion. Primarily, it is used for the treatment of Ovarian Cancer, Multiple Myeloma. Secondary and off-label uses of Oncophos 1000 mg Infusion have also been mentioned below.
The right dosage of Oncophos 1000 mg Infusion depends on the age, gender, and medical history of the patient. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Oncophos 1000 mg Infusion can also lead to other problems, which have been listed below. Such side effects of Oncophos 1000 mg Infusion normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Oncophos 1000 mg Infusion has a Severe effect for pregnant women and Severe effect on lactating mothers. Warnings related to Oncophos 1000 mg Infusion's effects on the liver, heart and kidney, if any, have been listed below.
Other contraindications of Oncophos 1000 mg Infusion have been discussed in the sections ahead.
Drug interactions for Oncophos 1000 mg Infusion have been reported in the medical literature. Refer to the list below for further details.
In addition to the above precautions for Oncophos 1000 mg Infusion, it is important to know that it is not safe while driving, and is not habit-forming.
Oncophos 1000 mg Infusion is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Geriatric |
|
Adult |
|
Is the use of Oncophos 1000 mg Infusion safe for pregnant women?
Oncophos can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Oncophos 1000 mg Infusion safe during breastfeeding?
Oncophos may cause serious side effects in breastfeeding women, so do not take this drug without doctor's advice.
What is the effect of Oncophos 1000 mg Infusion on the Kidneys?
Oncophos may have mild side effects on the kidneys.
What is the effect of Oncophos 1000 mg Infusion on the Liver?
Side effects of Oncophos rarely affect the liver.
What is the effect of Oncophos 1000 mg Infusion on the Heart?
Oncophos has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Oncophos 1000 mg Infusion unless your doctor advises you to do so -
Is this Oncophos 1000 mg Infusion habit forming or addictive?
Oncophos 1000 mg Infusion is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Oncophos 1000 mg Infusion. So it is best to avoid driving.
Is it safe?
Oncophos 1000 mg Infusion should be used only after doctor's advice.
Is it able to treat mental disorders?
Oncophos 1000 mg Infusion is unable to treat or cure mental disorders.
Interaction between Food and Oncophos 1000 mg Infusion
Taking Oncophos 1000 mg Infusion with food does not cause any problems.
Interaction between Alcohol and Oncophos 1000 mg Infusion
It is difficult to say anything about the effect of Oncophos 1000 mg Infusion and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Cyclophosphamide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 860
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 375-377